Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreLeveraging the power of the IQVIA CORE, we support Canada’s pharmaceutical manufacturers as they invest in, and advance, human health. We do this via breakthroughs in insights, technology, analytics and human intelligence that bring the progress in data science together with the possibilities of human science.
Learn MoreHospitals and healthcare providers are looking for cutting-edge decision support to augment their strategy and performance so they can focus on delivering high quality value to patients. As the Human Data Science Company, IQVIA is uniquely positioned to provide actionable data, innovative technology, and expertise customized to the hospital and provider community.
Learn MoreA specialized division of IQVIA (Canada), Health Industry Information Services (HIIS) serves the precise needs of non-pharmaceutical healthcare stakeholders including Retail Pharmacy, Independent Pharmacy, and Specialty Pharmacy.
Learn MoreAlmost everything we do is powered by the IQVIA CORE. This holistic approach allows us to use Human Data Science to create integrated solutions for our customers.
Learn MoreHealth benefit analytics for effective response to market changes.
Learn MoreTake your research further. Data assets that allow you to explore new areas in inquiry that can advance public health efforts. IQVIA supports the Canadian research community and has responded to hundreds of requests to support new areas of inquiry.
Learn MoreExplore our library of resources spanning the healthcare ecosystem. Hear from IQVIA data scientists, doctors, researchers, and other experts on the topics, trends, and market developments that matter to you.
Learn MoreMedia representatives and other industry stakeholders can access current and historical top-line Canada and global pharmaceutical trends for use in story development or vital health research.
Learn MoreCompte tenu des préoccupations croissantes en matière de santé publique dans tout le pays, IQVIA a produit une étude indépendante avec une visée de service public — Rapport sur les tendances d'utilisation des opioïdes au Canada — qui repose sur nos jeux de données uniques et notre expertise analytique relativement à l'utilisation des médicaments sur ordonnance. Les statistiques comparatives 2019-2023 sur les variations de la dispensation des ordonnances d'opioïdes présentées dans le rapport proviennent du tableau de bord d'IQVIA, élaboré dans le cadre d'une collaboration avec le Conseil consultatif pour l'avancement de la santé mis en place par IQVIA. Ce Conseil a pour mandat de promouvoir un meilleur accès et une meilleure utilisation des données sur la santé afin de contribuer à faire la lumière sur certains des problèmes de santé les plus difficiles auxquels sont confrontés les Canadiens.